rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    SOLV
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Is Wall Street Bullish or Bearish on Solventum Stock?
      20h agoBarchartSOLV
      Solventum (SOLV) stock trades up, here is why

      Shares of healthcare solutions provider Solventum (NYSE:SOLV) jumped 5% in the afternoon session after the company reported third-quarter 2026 financial results and raised its full-year adjusted earnings per share guidance.

      Nov 10Yahoo FinanceSOLV
      Solventum Q3 Earnings Call Highlights
      Nov 8Yahoo FinanceSOLV
      Solventum Earnings Call Signals Stronger Growth Ahead

      Tipranks Press Release.

      Nov 8The Globe and MailSOLV
      What Is Solventum (SOLV) Signaling With Its 90% Separation And HIS Split Plan?

      Solventum (NYSE:SOLV) reports that more than 90% of its separation from former parent 3M is now complete. The healthcare supplier has executed its largest ever ERP cutover, consolidating core systems into a new standalone platform. Management has renegotiated a raw material supply agreement with 3M and plans to separate the Health Information Systems business for clearer focus. The ERP cutover, 3M separation progress and planned Health Information Systems carve out only tell part of the...

      Nov 7Yahoo FinanceSOLV
      SOLV Q3 Earnings Beat Estimates Despite ERP-Related Revenues Decline
      Nov 6Yahoo FinanceSOLV
      Solventum stock price target raised to $100 by BTIG on results
      Nov 6Investing.comSOLV
      BTIG raises Solventum stock price target to $100 on strong results
      Nov 6Investing.comSOLV
      Solventum Corp (SOLV) Q3 2026 Earnings Call Highlights: Separation Nears Completion as EPS ...
      Nov 6Yahoo FinanceSOLV
      Solventum (NYSE:SOLV) beats Q3 2026 sales expectations
      Nov 5Yahoo FinanceSOLV
      Solventum Q3 2026 Earnings Call Transcript
      Nov 5BenzingaSOLV
      Solventum (SOLV) Tops Q3 Earnings Estimates

      Solventum (SOLV) delivered earnings and revenue surprises of +7.41% and -1.07%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

      Nov 5Yahoo FinanceSOLV
      Solventum: Q3 Earnings Snapshot
      Nov 5Yahoo FinanceSOLV
      Solventum Reports Third Quarter 2026 Financial Results
      Nov 5Yahoo FinanceSOLV
      Here's Why You Should Hold Solventum Stock in Your Portfolio for Now

      SOLV's strong Q2 performance, growth investments and cost-saving program support its outlook, though higher raw material costs remain a concern.

      Nov 5Yahoo FinanceSOLV
      Gear Up for Solventum (SOLV) Q3 Earnings: Wall Street Estimates for Key Metrics
      Nov 4Yahoo FinanceSOLV
      SOLV's Q3 Earnings: Can Growth Momentum Offset ERP-Related Headwinds?

      Solventum's Q3 results are likely to face ERP-related order reversals and tariff pressures, while MedSurg, Dental and Acera growth may have supported underlying performance.

      Nov 2Yahoo FinanceSOLV
      Solventum Corp. stock falls Friday, underperforms market
      Oct 30MarketWatchSOLV
      Solventum Corp. stock rises Thursday, outperforms market
      Oct 29MarketWatchSOLV
      Solventum (SOLV) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
      Oct 29Yahoo FinanceSOLV
      Solventum Corp. stock falls Wednesday, underperforms market
      Oct 28MarketWatchSOLV
      Solventum’s Quarterly Earnings Preview: What You Need to Know
      Oct 27BarchartSOLV
      Solventum Corp. stock falls Friday, underperforms market
      Oct 23MarketWatchSOLV
      SOLV Wins FDA Clearance to Combine Restrata Matrix With V.A.C.Therapy
      Oct 23Yahoo FinanceSOLV
      Solventum Corp. stock rises Tuesday, outperforms market
      Oct 20MarketWatchSOLV
      Solventum gets FDA clearance for combined wound care therapy
      Oct 19Investing.comSOLV
      Solventum Receives FDA Clearance for Combined Use of Wound Care Technologies
      Oct 19Yahoo FinanceSOLV
      Solventum Corp. stock falls Friday, underperforms market
      Oct 16MarketWatchSOLV
      Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026
      Oct 15Yahoo FinanceSOLV
      Solventum Corp. stock rises Wednesday, outperforms market
      Oct 14MarketWatchSOLV
      Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY) and Solventum Corporation (SOLV)

      Tipranks Press Release.

      Oct 12The Globe and MailALNYSOLV
      Solventum Corp. stock falls Monday, underperforms market
      Oct 12MarketWatchSOLV
      Solventum collecting initial bids for Health Information Systems business
      Oct 9AxiosSOLV
      Solventum Corp. stock rises Friday, outperforms market
      Oct 9MarketWatchSOLV
      Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive?
      Oct 8Yahoo FinanceSOLV
      Jefferies cuts Solventum stock price target to $34 on de-rating
      Oct 8Investing.comSOLV
      Solventum Corp. stock falls Wednesday, underperforms market
      Oct 7MarketWatchSOLV
      Solventum Corp. stock falls Tuesday, underperforms market
      Oct 6MarketWatchSOLV
      Rothschild & Co Redburn Adjusts Price Target on Solventum to $75 From $70, Maintains Sell Rating
      Oct 6Yahoo FinanceSOLV
      Solventum Corp. stock falls Wednesday, underperforms market
      Sep 30MarketWatchSOLV
      Solventum Corp. stock rises Friday, outperforms market
      Sep 25MarketWatchSOLV
      How Is Solventum's Stock Performance Compared to Other Healthcare Stocks
      Sep 25BarchartSOLV
      Solventum Corp. stock rises Friday, outperforms market
      Sep 18MarketWatchSOLV
      Stifel reiterates Solventum stock Buy rating, $100 price target
      Sep 18Investing.comSOLV
      Solventum: Divesture Unlocking Upside In A Spinoff Revaluation Play (NYSE:SOLV)
      Sep 18Seeking AlphaSOLV
      Solventum Corp. stock falls Thursday, underperforms market
      Sep 17MarketWatchSOLV
      Here's Why You Should Hold Solventum Stock in Your Portfolio for Now

      SOLV's strong Q2 performance, growth investments and cost-saving program support its outlook, though higher raw material costs remain a concern.

      Sep 17Yahoo FinanceSOLV
      What Solventum (SOLV)'s Earnings Beat and Surgical AI Push Means For Shareholders

      Earlier this quarter, Solventum reported results that surpassed analyst expectations, with both organic revenue and EPS beating estimates and management emphasizing strong execution and ongoing transformation efforts. An interesting angle is how Solventum’s exposure to surgical equipment and consumables, including AI and robotics-enabled solutions, supports relatively consistent procedural demand and innovation-driven opportunities. Now we’ll explore how this stronger-than-expected quarter,...

      Sep 17Yahoo FinanceSOLV
      Solventum Corp. stock falls Wednesday, underperforms market
      Sep 16MarketWatchSOLV
      Q2 Surgical Equipment & Consumables - Diversified Earnings: Solventum (NYSE:SOLV) Impresses

      As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at surgical equipment & consumables - diversified stocks, starting with Solventum (NYSE:SOLV).

      Sep 16Yahoo FinanceSOLV

      This is the newest page. Registered accounts read further back.